Lamictal Competitor Resource Kit

LAMICTAL

ARIPIPRAZOLE

LITHIUM

OLANZAPINE

QUETIAPINE

RISPERIDONE

SSRI

TOPIRAMATE

VALPROATE

ZIPRASIDONE

LAMICTAL

SUPPORTING DATA

Marketing information
Key claims
Prevents depression
Does not destabilize mood
Improves quality of life
Tolerability similar to placebo
Supporting data
No weight gain
13 years of experience
A new approach
Introduce at any phase
Can be used in combination
Country information
References

Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer


	1. Pivotal trial - index manic* Authors: Bowden CL, et al.; for the Lamictal 606 Study group. Title: A placebo-controlled... 2. Lamotrigine for acute depression* Authors: Calabrese JR, et al. Title: A double-blind placebo-controlled study of lamotrigine... 3. Factors in lamotrigine-related skin rash Authors: Wong ICK, et al. Title: Factors influencing the incidence of lamotrigine-related skin... 4. Lamotrigine and lithium in bipolar disorder* Authors: Goodwin GM, et al. Title: A pooled analysis of two placebo-controlled 18-month trials... 5. Lamotrigine prophylaxis for rapid cycling* Authors: Calabrese JR, et al.; for the Lamictal 614 Study Group. Title: A double blind,... 6. Rates of rash in multicenter trials* Authors: Calabrese RJ, et al. Title: Rash in multi-centre trials of lamotrigine in mood... 7. Lamotrigine safety review* Authors: Bowden CL, et al. Title: Safety and tolerability of lamotrigine for bipolar disorder.... 8. Low rate of rash with dermatology precautions Authors: Wang P, et al. Title: Low incidence of lamotrigine treatment-emergent rash with...